The proliferation REduction with vascular ENergy trial (PREVENT)

Current Controlled Trials in Cardiovascular Medicine

Volumn 2, Issue 1, 2001, Pages 16-19

  Raizner, Albert E ^a,b   Kaluza, Grzegorz L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Angioplasty; Beta radiation; Coronary artery disease; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; PHOSPHORUS 32; PLACEBO; TICLOPIDINE;

ARTERY DIAMETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; ELECTRON THERAPY; HEART INFARCTION; HOSPITALIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MORTALITY; NOTE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; Q WAVE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; STENOSIS; THROMBOSIS;

EID: 0035099220     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-2-1-016     Document Type: Note

References (7)

1. Prevention of coronary restenosis: The evolving evidence base for radiation therapy
2. Catheter-based radiotherapy to inhibit restenosis after coronary stenting
3. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis
4. Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: Results of the beta energy restenosis trial (BERT)
5. Intra-coronary beta-radiation therapy inhibits recurrence of in-stent restenosis
6. Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT)
7. Clinical experience with a spiral balloon centering catheter for the delivery of intracoronary radiation therapy